Pfizer Settles FCPA Charges; Sees Leniency Thanks to Proactive Compliance Steps

Washington Drug Letter
Pfizer will pay $60 million to resolve Foreign Corrupt Practices Act charges, but its proactive corporate compliance program allowed it to avoid even harsher penalties — including imposition of an outside corporate monitor.

To View This Article:


Buy This Article Now

Add this article to your cart for $25.00